KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Cash (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Change in Cash for 17 consecutive years, with -$12.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 94.42% to -$12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$129.0 million through Dec 2025, up 5.84% year-over-year, with the annual reading at -$129.0 million for FY2025, 5.84% up from the prior year.
  • Change in Cash hit -$12.0 million in Q4 2025 for Quest Diagnostics, down from $113.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $543.0 million in Q4 2023 to a low of -$670.0 million in Q2 2021.
  • Historically, Change in Cash has averaged -$36.9 million across 5 years, with a median of -$69.5 million in 2022.
  • Biggest five-year swings in Change in Cash: plummeted 322.22% in 2022 and later soared 2800.0% in 2024.
  • Year by year, Change in Cash stood at -$115.0 million in 2021, then tumbled by 234.78% to -$385.0 million in 2022, then skyrocketed by 241.04% to $543.0 million in 2023, then tumbled by 139.59% to -$215.0 million in 2024, then soared by 94.42% to -$12.0 million in 2025.
  • Business Quant data shows Change in Cash for DGX at -$12.0 million in Q4 2025, $113.0 million in Q3 2025, and $131.0 million in Q2 2025.